138 related articles for article (PubMed ID: 546729)
21. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
Larsen B; Heron I; Thorling EB
Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
[No Abstract] [Full Text] [Related]
22. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
[TBL] [Abstract][Full Text] [Related]
23. [Plasma copper and zinc levels in Hodgkin's disease].
Cappelaere P; Sulman C; Chechan C; Gosselin-Dulaquais P
Lille Med; 1975 Dec; 20(10):904-13. PubMed ID: 1207358
[No Abstract] [Full Text] [Related]
24. Alterations of plasma levels in malignant lymphoma.
Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
[TBL] [Abstract][Full Text] [Related]
25. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
[No Abstract] [Full Text] [Related]
26. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
[No Abstract] [Full Text] [Related]
27. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
Wolf PL; Ray G; Kaplan H
Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
[No Abstract] [Full Text] [Related]
28. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
Cepelja Z; Grgić Z; Markinković M; Ivanov D
Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
[No Abstract] [Full Text] [Related]
29. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
Jelliffe AM
Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
[No Abstract] [Full Text] [Related]
30. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
[TBL] [Abstract][Full Text] [Related]
31. Behavior of total serum complement in Hodgkin's disease and other malignant lymphomas.
ROTTINO A; LEVY AL
Blood; 1959 Mar; 14(3):246-54. PubMed ID: 13628822
[No Abstract] [Full Text] [Related]
32. Changes in serum copper and serum ceruloplasmin concentration induced by surgical trauma.
Hallböök T; Hedelin H
Acta Chir Scand; 1980; 146(6):371-3. PubMed ID: 7468069
[TBL] [Abstract][Full Text] [Related]
33. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
34. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
Kamthan M; Joshi N; Sharma ML
Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
[No Abstract] [Full Text] [Related]
35. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
Wu HY
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
[TBL] [Abstract][Full Text] [Related]
36. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease].
Pisi E; Di Feliciantonio R; Figus E; Ferri S
Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623
[No Abstract] [Full Text] [Related]
37. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
RECHENBERGER J
Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
[No Abstract] [Full Text] [Related]
38. Serum copper, ceruloplasmin and thiobarbituric acid reactive substance status in patients with ovarian cancer.
Nayak SB; Bhat VR; Mayya SS
Indian J Physiol Pharmacol; 2004 Oct; 48(4):486-8. PubMed ID: 15907060
[TBL] [Abstract][Full Text] [Related]
39. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
[No Abstract] [Full Text] [Related]
40. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
